In the US, Ticagrelor (ticagrelor systemic) is a member of the drug class platelet aggregation inhibitors and is used to treat Acute Coronary Syndrome, Heart Attack, Myocardial Infarction - Prophylaxis and Prevention of Atherothrombotic Events.
ATC (Anatomical Therapeutic Chemical Classification)
CAS registry number (Chemical Abstracts Service)
Antiplatelet agent inhibiting adenosine diphosphate-mediated platelet aggregation
1,2-Cyclopentanediol, 3-[7-[[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino]-5-(propyltio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyetoxy)-, (1S,2S,3R,5S)- (USAN)
- Ticagrelorum (Latin)
- Ticagrelor (German)
- Ticagrélor (French)
- Ticagrelor (Spanish)
- Ticagrelor (OS: BAN, USAN, JAN)
- AR-C126532XX (IS)
- AZD6140 (IS)
- UNII-GLH0314RVC (IS)
AstraZeneca, Australia; AstraZeneca, Canada; AstraZeneca, China; AstraZeneca, Colombia; AstraZeneca, Georgia; AstraZeneca, Indonesia; AstraZeneca, Israel; AstraZeneca, South Korea; AstraZeneca, Lebanon; AstraZeneca, Mexico; AstraZeneca, Malaysia; AstraZeneca, New Zealand; AstraZeneca, Philippines; AstraZeneca, Thailand; AstraZeneca, Turkey; AstraZeneca, United States; AstraZeneca Singapore, Singapore
AstraZeneca, Austria; AstraZeneca, Belgium; AstraZeneca, Denmark; AstraZeneca, Spain; AstraZeneca, Finland; AstraZeneca, Greece; AstraZeneca, Croatia (Hrvatska); AstraZeneca, Hungary; AstraZeneca, Ireland; AstraZeneca, Iceland; AstraZeneca, Lithuania; AstraZeneca, Latvia; AstraZeneca, Norway; AstraZeneca, Poland; AstraZeneca, Portugal; AstraZeneca, Romania; AstraZeneca, Slovenia; AstraZeneca, Slovakia; AstraZeneca AB, Cyprus; AstraZeneca UK, United Kingdom; AstraZeneca, Switzerland; AstraZeneca, Germany; AstraZeneca, France; AstraZeneca, Sweden; AstraZeneca AB-S, Italy
AstraZeneca, Lithuania; AstraZeneca, Netherlands
|BAN||British Approved Name|
|JAN||Japanese Accepted Name|
|Rec.INN||Recommended International Nonproprietary Name (World Health Organization)|
|USAN||United States Adopted Name|
|WHO||World Health Organization|
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.